Filing Flows › Bio-Rad Laboratories (BIO) › Gross margin
Bio-Rad Laboratories (BIO) gross margin by quarter
Bio-Rad Laboratories' gross margin was 53.1% in Q2 2026 (second quarter 2026), +0.1 pts from Q2 2025. Over the last 3 quarters it ranged from 52.3% (Q1 2025) to 53.1% (Q2 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 53.1% | +0.1 pts | +0.1 pts |
| Q2 2025 | 53.0% | +0.7 pts | — |
| Q1 2025 | 52.3% | — | — |
Q2 2026 at a glance
Bio-Rad Laboratories, Q2 2026: revenue $651M (-0.1% year over year), operating margin 11.2%, net earnings $371M, operating cash flow $98.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Rad Laboratories' gross margin?
Bio-Rad Laboratories' gross margin was 53.1% in Q2 2026 (second quarter 2026), +0.1 pts from Q2 2025.
How has Bio-Rad Laboratories' gross margin changed?
Over the last 3 quarters it ranged from 52.3% (Q1 2025) to 53.1% (Q2 2026).